Significance of basic fibroblast growth factor and fibroblast growth factor receptor protein expression in the formation of fibrotic focus in invasive ductal carcinoma of the breast

Japanese Journal of Cancer Research

Volumn 88, Issue 9, 1997, Pages 877-885

  Hasebe, Takahiro ^a   Imoto, Shigeru ^a   Ogura, Tsutomu ^b   Mukai, Kiyoshi ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Basic fibroblast growth factor; Fibroblast growth factor receptor; Fibrotic focus; Immunohistochemistry; Invasive ductal carcinoma

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST DUCT; CANCER INVASION; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOLID TUMOR; TUMOR CELL;

EID: 0030721771     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1997.tb00464.x     Document Type: Article

References (24)

1. Hasebe, T., Tsuda, H., Hirohashi, S., Shimosato, Y., Iwai, M, Imoto, S. and Mukai, K. Fibrotic focus in invasive ductal carcinoma: an indicator of high tumor aggressiveness. Jpn. J. Cancer Res., 87, 385-394 (1996).
2. Rifkin, D. B. and Moscatelli, D. Recent developments in the cell biology of basic fibroblast growth factor. J. Cell Biol., 109, 1-6 (1989).
3. Gospodarowicz, D. The fibroblast growth factor. Oncogenesis, 1, 1-25 (1989).
4. Souttou, B., Hamelin, R. and Crepin, M. FGF2 as an autocrine growth factor for immortal human breast epithelial cells. Cell Growth Differ., 5, 615-623 (1994).
5. Luamani, Y. A., Graham, M. and Coombes, R. C. Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant breast, and comparison with other normal tissues. Br. J. Cancer, 66, 273-280 (1992).
6. Jonson, D. E. and Williams, L. T. Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res., 60, 1-41 (1993).
7. Jacquemier, J., Adelaide, J., Parc, P., Penault-Llorca, F., Planche, J., DeLapeyriere, O. and Birnbaum, D. Expression of the FGFR1 gene in human breast carcinoma cells. Int. J. Cancer, 59, 373-378 (1994).
8. Rosenbaum, J., Blazejewski, S., Anne-Marie, P., Mallat, A., Dhumeaux, D. and Mavier, P. Fibroblast growth factor 2 and transforming growth factor β1 interactions in human liver myofibroblasts. Gastroenterology, 109, 1986-1996 (1995).
9. Wilson, S. E., Lioyd, S. A. and He, Y. G. Fibroblast growth factor-1 receptor messenger RNA expression in corneal cells. Cornea, 12, 249-254 (1993).
10. WHO. Histological typing of breast tumors. In "International Histological Classification of Tumors," 2nd Ed., p. 806 (1981). World Health Organization, Geneva, Switzerland.
11. Hsu, S. M., Raine, L. and Fanger, H. The use of avidinbiotin-peroxidase complex (ABC) in immunoperoxidase technique: a comparison between ABC and unlabelled antibody (PAP) procedures. J. Histochem. Cytochem., 29, 577-580 (1981).
12. Shi, S. R., Key, M. E. and Kalza, K. L. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J. Histochem. Cytochem., 39, 741-746 (1991).
13. Li, S. and Shipley, G. D. Expression of multiple species of basic fibroblast growth factor mRNA and protein in normal and tumor-derived mammary epithelial cells in culture. Cell Growth Differ., 2, 195-202 (1991).
14. Masuda, Y., Yoshitake, Y. and Nishikawa, K. Growth control of A431 cells in protein-free medium: secretory products do not affect cell growth. In Vitro Cell. Dev. Biol., 24, 893-899 (1988).
15. Nishikawa, K., Yoshitake, Y., Okitsu, C. and Adachi, K. Growth factors localized in tumor nuclei. In "Control Mechanisms in Animal Cells," ed. L. Jimenez de Asua, R. Levi-Nontalcini, R. Schields and S. Iacobelli, pp. 279-284 (1980). Raven Press, New York.
16. Yoshitake, Y., Nishikawa, K. and Adachi, K. DNA synthesis-stimulating activities for BALB/3T3 cells present in histone and nonhistone protein fractions from rat Rhodamine fibrosarcoma. Cell Struct. Funct., 7, 229-243 (1982).
17. Hasebe, T., Tsuda, H., Tsubono, Y., Imoto, S. and Mukai, K. Fibrotic focus in invasive ductal carcinoma of the breast: a histopathological prognostic parameter for tumor recurrence and tumor death within three years after the initial operation. Jpn. J. Cancer Res., 88, 590-599 (1997).
18. Yiangou, C., Gomm, J. J., Coope, R. C., Law, M., Luqmani, Y. A., Shousha, S., Coombes, R. C. and Johnston, C. L. Fibroblast growth factor 2 in breast cancer: occurrence and prognostic significance. Br. J. Cancer, 75, 28-33 (1997).
19. Whitby, D. J. and Ferguson, M. W. Immunohistochemical localization of growth factors in fetal wound healing. Dev. Biol., 147, 207-215 (1991).
20. Pierce, G. F., Tarpley, J. E., Yanagihara, D., Mustoe, T. A., Fox, G. M. and Thomason, A. Platelet-derived growth factor (BB homodimer), transforming growth factor-β1, and basic fibroblast growth factor in dermal wound healing. Am. J. Pathol., 140, 1375-1388 (1992).
21. Henke, C., Marineili, W., Jessurun, J., Fox, J., Harms, D., Peterson, M., Chiang, L. and Doran, P. Macrophage production of basic fibroblast growth factor in the fibroproliferative disorder of alveolar fibrosis after lung injury. Am. J. Pathol., 143, 1189-1199 (1993).
22. Friess, H., Yamanaka, Y., Büchler, M., Beger, H. G., Do, D. A., Kobrin, M. S. and Korc, M. Increased expression of acidic and basic fibroblast growth factors in chronic pancreatitis. Am. J. Pathol., 144, 117-128 (1994).
23. Fisher, B., Bauer, M., Wickerman, L., Redmond, C. K. and Fisher, E. R. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. Cancer, 52, 1551-1557 (1983).
24. Carter, C. L., Allen, C. and Henson, D. E. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer, 63, 181-187 (1989).